Authors: Frangione-Beebe, M Rose, RT Kaumaya, PTP Schwendeman, SP

Citation: M. Frangione-beebe et al., Microencapsulation of a synthetic peptide epitope for HTLV-1 in biodegradable poly(D,L-lactide-co-glycolide) microspheres using a novel encapsulationtechnique, J MICROENC, 18(5), 2001, pp. 663-677

Authors: Frangione-Beebe, M Albrecht, B Dakappagari, N Rose, RT Brooks, CL Schwendeman, SP Lairmore, MD Kaumaya, PTP

Citation: M. Frangione-beebe et al., Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide (vol 19, pg 1068, 2001), VACCINE, 19(28-29), 2001, pp. 4087-4087

Authors: Srinivasan, M Wardrop, RM Gienapp, IE Stuckman, SS Whitacre, CC Kaumaya, PTP

Citation: M. Srinivasan et al., A retro-inverso peptide mimic of CD28 encompassing the MYPPPY motif adoptsa polyproline type II helix and inhibits encephalitogenic T cells in vitro, J IMMUNOL, 167(1), 2001, pp. 578-585

Authors: Frangione-Beebe, M Albrecht, B Dakappagari, N Rose, RT Brooks, CL Schwendeman, SP Lairmore, MD Kaumaya, PTP

Citation: M. Frangione-beebe et al., Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide, VACCINE, 19(9-10), 2000, pp. 1068-1081

Authors: Dakappagari, NK Douglas, DB Triozzi, PL Stevens, VC Kaumaya, PTP

Citation: Nk. Dakappagari et al., Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine, CANCER RES, 60(14), 2000, pp. 3782-3789

Authors: Kaumaya, PTP

Citation: Ptp. Kaumaya, Special issue: Advances in peptide, protein & nucleic acid. Vaccine strategies, VACCINE, 18(3-4), 1999, pp. 203-203